Endogenous p53 inhibitor TIRR dissociates systemic metabolic health from oncogenic activity.
Tsaousidou E, Chrzanowski J, Drané P, Lee GY, Bahour N, Wang ZB, Deng S, Cao Z, Huang K, He Y, Kaminski M, Michalek D, Güney E, Parmar K, Fendler W, Chowdhury D, Hotamışlıgil GS.
Tsaousidou E, et al. Among authors: huang k.
Cell Rep. 2024 Jun 9;43(6):114337. doi: 10.1016/j.celrep.2024.114337. Online ahead of print.
Cell Rep. 2024.
PMID: 38861384